Page last updated: 2024-08-23

pimonidazole and rrx-001

pimonidazole has been researched along with rrx-001 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabrales, P; Minchinton, A; Oronsky, B; Scicinski, J1

Other Studies

1 other study(ies) available for pimonidazole and rrx-001

ArticleYear
RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors.
    Clinical epigenetics, 2016, Volume: 8

    Topics: Actins; Animals; Antineoplastic Agents; Azetidines; Cell Hypoxia; Cell Line, Tumor; Epigenesis, Genetic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neoplasm Transplantation; Neoplasms; Nitro Compounds; Nitroimidazoles; Tumor Microenvironment

2016